Zurich Cantonal Bank
LKFT

Zurich Cantonal Bank’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Zurich Cantonal Bank’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-281
Closed -$9.19K – 2953
2025
Q4 		$9.19K Buy
+281
New +$9.07K ﹤0.01% 2488

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Zurich Cantonal Bank's LKFT Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 281 shares — an estimated $9.07K sold.

Zurich Cantonal Bank first reported a position in LKFT in Q1 2022 and held it in 7 quarters. The position peaked at $34K in Q1 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 281 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $9.07K.
  • Zurich Cantonal Bank first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2022 and held it in 7 quarters.
  • Zurich Cantonal Bank's Lakefront Biotherapeutics American Depositary Shares position peaked at $34K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.